GO	[-31.63 -1.16]	[-1.16 -0.63]	[-0.63 -0.34]	[-0.34 -0.15]	[-0.15 0.00]	[0.00 0.00]	[0.00 0.05]	[0.05 0.24]	[0.24 0.53]	[0.53 1.14]	[1.14 23.45]
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.327	-1.114	-1.997	-0.560	-2.385	-3.939	-0.714	-1.997	0.277	4.966	13.093
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	1.714	0.593	-2.021	-0.914	-3.971	-1.681	-1.386	-1.681	0.360	4.523	4.937
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	2.275	-1.837	-0.659	-2.597	-3.592	0.944	-0.302	-2.192	0.944	1.535	3.506
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	0.289	-0.313	-0.473	-2.547	-0.691	2.415	-0.981	-1.868	-1.364	0.435	6.499
ROSS_AML_WITH_CBFB_MYH11_FUSION ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.535	-0.865	-0.316	-0.865	-0.865	-2.156	-1.362	1.017	1.761	0.720	3.231
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN KOBAYASHI_RESPONSE_TO_ROMIDEPSIN	-0.324	-0.324	-0.787	-0.787	-0.787	-0.787	-0.787	1.613	-0.324	0.609	3.865
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.352	1.245	0.643	-1.125	-0.486	-3.511	-0.867	-0.867	0.361	1.245	2.721
ZHAN_MULTIPLE_MYELOMA_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD2_UP	-0.451	-0.755	-0.451	-0.451	-0.256	-1.225	-1.225	-0.755	2.001	1.180	2.493
GAVIN_FOXP3_TARGETS_CLUSTER_P4 GAVIN_FOXP3_TARGETS_CLUSTER_P4	0.896	-0.373	-0.373	-0.373	-0.537	-2.399	-1.381	-0.537	0.896	0.507	3.180
